Patent · US Active

MAD nucleases

US11053485B2 · kind B2 · utility

2Cited by
17References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 29, 2020
Grant dateJul 6, 2021
Priority date—
Expiry dateOct 29, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/80
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present disclosure provides new RNA-guided nucleases for making rational, direct edits to nucleic acids in live cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.